For: | Tan YX, Wang HT, Zhang P, Yan ZH, Dai GL, Wu MC, Wang HY. c-src activating mutation analysis in Chinese patients with colorectal cancer. World J Gastroenterol 2005; 11(15): 2351-2353 [PMID: 15818752 DOI: 10.3748/wjg.v11.i15.2351] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i15/2351.htm |
Number | Citing Articles |
1 |
Takashi Kanou, Chitose Oneyama, Kunimitsu Kawahara, Akira Okimura, Mitsunori Ohta, Naoki Ikeda, Yasushi Shintani, Meinoshin Okumura, Masato Okada. The Transmembrane Adaptor Cbp/PAG1 Controls the Malignant Potential of Human Non–Small Cell Lung Cancers That Have c-Src Upregulation. Molecular Cancer Research 2011; 9(1): 103 doi: 10.1158/1541-7786.MCR-10-0340
|
2 |
Anne S. Tsao, Dandan He, Babita Saigal, Suyu Liu, J. Jack Lee, Srinivasa Bakkannagari, Nelson G. Ordonez, Waun Ki Hong, Ignacio Wistuba, Faye M. Johnson. Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion. Molecular Cancer Therapeutics 2007; 6(7): 1962 doi: 10.1158/1535-7163.MCT-07-0052
|
3 |
Ami N. Shah, Gary E. Gallick. Src, chemoresistance and epithelial to mesenchymal transition: are they related?. Anti-Cancer Drugs 2007; 18(4): 371 doi: 10.1097/CAD.0b013e32801265d7
|
4 |
Leonardo Marques da Fonseca, Vanessa Amil da Silva, Kelli Monteiro da Costa, Jhenifer Santos dos Reis, José Osvaldo Previato, Lucia Mendonça Previato, Leonardo Freire-de-Lima. Resistance to cisplatin in human lung adenocarcinoma cells: effects on the glycophenotype and epithelial to mesenchymal transition markers. Glycoconjugate Journal 2022; 39(2): 247 doi: 10.1007/s10719-022-10042-2
|
5 |
Christina Leah B. Kline, Rosalind Jackson, Robert Engelman, Warren Jack Pledger, Timothy J. Yeatman, Rosalyn B. Irby. Src kinase induces tumor formation in the c‐SRC C57BL/6 mouse. International Journal of Cancer 2008; 122(12): 2665 doi: 10.1002/ijc.23445
|
6 |
H Wang, B Liu, A Q O Al-Aidaroos, H Shi, L Li, K Guo, J Li, B C P Tan, J M Loo, J P Tang, M Thura, Q Zeng. Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans. Oncogene 2016; 35(25): 3303 doi: 10.1038/onc.2015.391
|